Endocrine System, Pregnancy, Prevention Program
Conditions
Keywords
bisphenol-A, prevention, endocrine disruptors
Brief summary
Endocrine disruptors are known as a cancer cause. On pregnant women, it can induce major foetal pathology and impact growth. Among those molecules, bisphenol-A (BPA) is a plasticizer that can be found on cans and water. Through a prevention program, the investigators tried to warned pregnant women on endocrine disruptors exposition risks. The goal here is to assess the effectiveness of this program on their fresh products consumption.
Interventions
BEHAVIORALsensibilisation program Ma maison, mon environnement santé
The aim of this program is to spread the awarness about endocrine disruptors through workshops and presentation.
Sponsors
Poitiers University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Patients over 18 * Patients living in Poitiers or city around (near the immersive environment) * Patients on pregnancy and who declared their pregnancy to the authority * Patients who planned to give birth in Poitiers's hospital, Châtellerault's hospital or Clinique Fief de Grimoire, in Poitiers. * Patients giving her agreement
Exclusion criteria
* Patients planning to move during the study * Patients under legal protection * Patients expecting twins * Patients unable to speak french * Patients willing to give birth in another hospital than those mentionned before
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| program effectivness | During the pregnancy (second and third trimester) | Assessing the Effectiveness of the Prevention Program My Home, My Health Environment (consists of a series of workshop in the second and third trimesters of pregnancy) in an immersive environment or not, to evaluate the consumption of fresh products according to exposure endocrine disruptors (cans or industrial products). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| psychosocial aspects | During the pregnancy (second and third trimester) | Assess if the program impact any psychosocial aspects, this outcome will be determine with a psychosocial questionary (to do before and after the intervention for compare the results) |
| Urine concentration | During the pregnancy (second and third trimester) | Assess if the program has an impact on the urinary endocrine disruptors's concentrations, this outcome will be determine with samples of urine (to do before and after the intervention for comparate the results) |
| Milk concentration | After the birth of the child (first year) | Assess the milk endocrine disruptors's concentration difference between women exposed and unexposed to the program |
| foetal growth | After the birth of the child (first year) | Study the relation between endocrine disruptors expositions and foetal growth by merging PREVED and EDDS (a previous trial) datas. |
Countries
France
Outcome results
None listed